Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK/ERK

Yudong Tian1, Yanbin Guan, Yongyan Jia

  • 11 Department of Urology Surgery, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, China .

Abstract

Insights

Chloride intracellular channel 1 (CLIC1) knockdown inhibits prostate cancer cell proliferation and migration by affecting the MAPK/ERK pathway. This suggests CLIC1 is a potential therapeutic target for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Prostate cancer remains a leading cause of cancer-related deaths globally.
  • Understanding the molecular mechanisms driving prostate cancer progression is crucial for developing effective therapies.
  • Chloride intracellular channel 1 (CLIC1) has been implicated in various cellular processes, but its role in prostate cancer requires further elucidation.

Purpose of the Study:

  • To investigate the functional role of CLIC1 in prostate cancer cell lines PC-3 and DU145.
  • To explore the underlying molecular mechanisms by which CLIC1 influences cancer cell proliferation, migration, and apoptosis.
  • To assess the potential of CLIC1 as a therapeutic target for prostate cancer.

Main Methods:

  • RNA interference was employed to downregulate CLIC1 expression in PC-3 and DU145 cells.
  • Cell proliferation was assessed using MTT assays.
  • Cell migration was evaluated using Transwell chamber assays.
  • Apoptosis was analyzed by flow cytometry.
  • Western blotting was used to measure the levels of p-ERK1/2, ERK1/2, MMP-2, and MMP-9.

Main Results:

  • Downregulation of CLIC1 significantly inhibited the proliferation and migration of PC-3 and DU145 prostate cancer cells.
  • CLIC1 knockdown did not affect the apoptosis rates in these cell lines.
  • The levels of phosphorylated ERK1/2 (p-ERK1/2), MMP-2, and MMP-9 were reduced in cells with CLIC1 knockdown.

Conclusions:

  • CLIC1 plays a significant role in regulating prostate cancer cell proliferation and migration.
  • The observed effects are mediated through the modulation of the mitogen-activated protein kinase (MAPK)/ERK signaling pathway.
  • CLIC1 represents a promising molecular target for the development of novel prostate cancer prevention and treatment strategies.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K